Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

Ross, R. K., Nunes, E. V., Olfson, M., Shulman, M., Krawczyk, N., Stuart, E. A., & Rudolph, K. E. (2024). Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Addiction. Portico. https://doi.org/10.1111/add.16630
Authors:
Rachael K Ross
Edward V Nunes
Mark Olfson
Matisyahu Shulman
Noa Krawczyk
Elizabeth A Stuart
Kara E Rudolph
Affiliated Authors:
Rachael K Ross
Edward V Nunes
Mark Olfson
Matisyahu Shulman
Kara E Rudolph
Columbia Affiliation:
Author Keywords:
extended-release naltrexone
medicaid
opioid use disorder
overdose
sublingual buprenorphine
treatment retention
extended‐release naltrexone
elink
Publication Type:
Article
Unique ID:
10.1111/add.16630
PMID:
39099417
DOI:
10.1111/add.16630
Journal:
Addiction
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: